138 related articles for article (PubMed ID: 30216231)
21. Trichomoniasis. An update on diagnostic tools and treatments.
Reyes M
Adv Nurse Pract; 2008 Apr; 16(4):69-70, 72. PubMed ID: 19999494
[No Abstract] [Full Text] [Related]
22. Prevalence and Correlates of Trichomonas vaginalis Infection Using the OSOM Rapid Point-of-Care Test Among Women Attending New York City Sexual Health Clinics, May-July 2016.
Fallon SA; Pathela P; Mikati T
Sex Transm Dis; 2019 Nov; 46(11):748-750. PubMed ID: 31356528
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of infections with Trichomonas vaginalis in the light of improved diagnostic methods.
WHITTINGTON MJ
Br J Vener Dis; 1957 Jun; 33(2):80-91. PubMed ID: 13446423
[No Abstract] [Full Text] [Related]
24. Multiattribute Analysis of
Ghallab MMI; Alaa D; Morsy SM
Infect Dis Obstet Gynecol; 2021; 2021():5525095. PubMed ID: 34012232
[TBL] [Abstract][Full Text] [Related]
25. Trichomoniasis among men presenting to a sexual health clinic in Melbourne, Australia.
Webb B; Graham M; Korman TM
Sex Health; 2022 Oct; 19(5):484-485. PubMed ID: 35786429
[TBL] [Abstract][Full Text] [Related]
26. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
27. Trichomoniasis.
Van Gerwen OT; Opsteen SA; Graves KJ; Muzny CA
Infect Dis Clin North Am; 2023 Jun; 37(2):245-265. PubMed ID: 37005163
[TBL] [Abstract][Full Text] [Related]
28. Audit of Trichomonas vaginalis test requesting by community referrers after a change from culture to molecular testing, including a cost analysis.
Bissessor L; Wilson J; McAuliffe G; Upton A
N Z Med J; 2017 Jun; 130(1457):34-37. PubMed ID: 28617786
[TBL] [Abstract][Full Text] [Related]
29. British Association for Sexual Health and HIV (BASHH) United Kingdom national guideline on the management of
Sherrard J; Pitt R; Hobbs KR; Maynard M; Cochrane E; Wilson J; Tipple C
Int J STD AIDS; 2022 Jul; 33(8):740-750. PubMed ID: 35701863
[TBL] [Abstract][Full Text] [Related]
30. Identification of volatile biomarkers of Trichomonas vaginalis infection in vaginal discharge and urine.
Rubio-Sánchez R; Ríos-Reina R; Ubeda C
Appl Microbiol Biotechnol; 2023 May; 107(9):3057-3069. PubMed ID: 37000228
[TBL] [Abstract][Full Text] [Related]
31. Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women.
Schwebke JR; Gaydos CA; Davis T; Marrazzo J; Furgerson D; Taylor SN; Smith B; Bachmann LH; Ackerman R; Spurrell T; Ferris D; Burnham CA; Reno H; Lebed J; Eisenberg D; Kerndt P; Philip S; Jordan J; Quigley N
J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167292
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea.
Kim SR; Kim JH; Gu NY; Kim YS; Hong YC; Ryu JS
Korean J Parasitol; 2016 Apr; 54(2):187-90. PubMed ID: 27180577
[TBL] [Abstract][Full Text] [Related]
33. Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases.
Pereyre S; Laurier Nadalié C; Bébéar C;
Clin Microbiol Infect; 2017 Feb; 23(2):122.e1-122.e7. PubMed ID: 27836808
[TBL] [Abstract][Full Text] [Related]
34. Detecting asymptomatic Trichomonas vaginalis in females using the BD ProbeTec™ Trichomonas vaginalis Q
Lord E; Newnham T; Dorrell L; Jesuthasan G; Clarke L; Jeffery K; Sherrard J
Int J STD AIDS; 2017 Mar; 28(4):357-361. PubMed ID: 27150360
[TBL] [Abstract][Full Text] [Related]
35. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
[TBL] [Abstract][Full Text] [Related]
36. Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands.
de Jong AS; Rahamat-Langendoen JC; van Alphen P; Hilt N; van Herk C; Pont S; Melchers W; van de Bovenkamp J
Int J STD AIDS; 2016 Sep; 27(10):856-60. PubMed ID: 26199286
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and cervical organism burden among Louisiana women with Trichomonas vaginalis infections.
Shaw MK; Porterfield HS; Favaloro S; Dehon PM; Van Der Pol B; Quayle AJ; McGowin CL
PLoS One; 2019; 14(6):e0217041. PubMed ID: 31220094
[TBL] [Abstract][Full Text] [Related]
38. Cross-sectional study to evaluate
Nicholls JE; Turner KME; North P; Ferguson R; May MT; Gough K; Macleod J; Muir P; Horner PJ
Sex Transm Infect; 2018 Mar; 94(2):93-99. PubMed ID: 28798195
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Trichomonas vaginalis infection in and around Surat.
Chakraborty T; Mulla SA; Kosambiya JK; Desai VK
Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
[TBL] [Abstract][Full Text] [Related]
40. The prevalence and risk factors of Trichomonas vaginalis in Wuhan and the Tibetan area, China: a two-center study.
Zhu X; Liu L; Yixi L; Yang Y; Zhang Y; Yang Z; Chen H; Dong J; Yang S
Parasitol Res; 2023 Jan; 122(1):265-273. PubMed ID: 36434317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
